fda tirzepatide approval Lilly's Mounjaro receives for type 2 diabetes treatment Day 4: Zepbound (Tirzepatide –

Injections are given every six months and should be administered by a healthcare professional only

Selpercatinib (160 mg twice daily) showed remarkable and durable efficacy in MTC with or without prior vandetanib or cabozantinib treatment in phase 1/2 trials (LIBRETTO-001 trial) (Table 3) [34]

For most trips, injecting on the same calendar day of the week at your destination works well

Wegovy or Ozempic (semaglutide): Another GLP-1 receptor agonist approved by the FDA for weight management with benefits for both weight loss and improving blood sugar

Treatment begins at a lower dose, with increases typically made every four weeks

Potential drug interactions, especially those that have a narrow therapeutic index or require close monitoring, such as oral anticoagulants, antiplatelet agents, antihypertensive medications, and other antidiabetic medications (1,3)